News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
新華製藥(00719.HK)：人工牛黃甲硝唑膠囊持有人轉讓申請獲批
山東新華製藥股份(00719.HK)公布，收到國家藥品監督管理局核准簽發的人工牛黃甲硝唑膠囊《藥品補充申請批准通知書》，批准該藥品持有人由中晟製藥變更為新華製藥。2023年9月，新華製藥與中晟製藥簽訂了生產技術及持有人轉讓合同，中晟製藥將擬取得的人工牛黃甲硝唑膠囊的製劑生產批件及商業化權益等所有MAH權益，包括但不限於產品生產、銷售、市場推廣等，一次性全部轉...
Reset
Send
The window will close in 5 seconds
新華製藥(00719.HK)：人工牛黃甲硝唑膠囊持有人轉讓申請獲批
Close
Recommend
2
Positive
0
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

山東新華製藥股份(00719.HK)  +0.020 (+0.337%)    Short selling $95.40K; Ratio 6.258%   公布，收到國家藥品監督管理局核准簽發的人工牛黃甲硝唑膠囊《藥品補充申請批准通知書》，批准該藥品持有人由中晟製藥變更為新華製藥。

2023年9月，新華製藥與中晟製藥簽訂了生產技術及持有人轉讓合同，中晟製藥將擬取得的人工牛黃甲硝唑膠囊的製劑生產批件及商業化權益等所有MAH權益，包括但不限於產品生產、銷售、市場推廣等，一次性全部轉讓給新華製藥，新華製藥根據合同約定向中晟製藥分階段支付相關轉讓費。(ss/a)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-05 16:25.)

Switch to Auto-Translated Version
AASTOCKS新聞
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.